Patients Coming Off Slimming Injections Regain Weight at a Quadrupled Rate Compared to People Using Diet and Exercise
Fresh analysis indicates that people who stop using blockbuster weight-loss injections like Wegovy and Mounjaro tend to recover reduced body mass at a significantly accelerated pace than those who stop traditional diet and exercise regimens.
Published data in a prominent health publication points out that while overweight people frequently drop about a fifth of their total mass while using the jabs, the weight comes back at an estimated rate of nearly a kilo each month after stopping.
"Individuals buying such drugs must be cognizant of the potential of quick weight regain when the medication is stopped," stated expert Dr. Susan Jebb.
That rate of recovery means a reversion to starting weight in about one and a half years.
Weighing Approaches
The research, which examined 37 of studies involving thousands of participants, compared the outcomes of these new drugs with older methods.
Scientists point out that individuals who lose weight through diet and exercise typically have a more gradual weight regain—perhaps 0.1 kg a month—once they finish.
The Reason for the Quick Rebound
Nutrition scientists believe the way of the injections accounts for the amplified weight return.
The injections mimic a natural hormone called glucagon-like peptide-1, which controls hunger.
"Long-term administration of the hormone levels far above than the body's typical production might result in the body to generate a reduced amount of its endogenous hormone, and could diminish responsiveness to its effects," said Dr. Adam Collins, a nutrition researcher.
"Stopping of this medication results in hunger is uncontrolled, making overeating a significant risk."
A Lifelong Issue?
Health authorities advise the jabs for people with weight-linked health risks, accompanied by prescribed lifestyle changes.
Professionals say that, given the high risk of relapse, the treatment should be considered ongoing.
This view is echoed by pharmaceutical companies, who state that the results "highlight the chronic character of excess weight," similar to managing diseases like high blood pressure.
User Testimonies
Individuals who have stopped the medication report a intense resurgence of appetite.
"I experienced a switch activating and I was suddenly extremely hungry," said one woman.
This difficulty is exacerbated if users have not developed sustainable lifestyle or habit changes during treatment.
Significant Interest
Figures suggest that a significant number of people in the UK have tried weight-loss jabs in the last 12 months, with demand continuing to grow.
- Adoption is higher among women than men.
- The 40s and 50s age group shows the highest usage rates.
- Many access the drugs through private prescriptions rather than the NHS.
Finally, clinicians caution that while the jabs are potent tools for shedding pounds, they are not a magic fix and maintained weight loss hinges on ongoing lifestyle management.